All companies
Visit website
Elevate Nutrition
OperatingElevate Nutrition Inc.
Retail & Consumer · Founded 2017
High Performance Plant-Based Nutrition
Post-money valuation ⓘ
$5.2M
As of Apr 2020 · from Elevate Equity 1 · pre-money + amount raised, not a traded price
Total raised
$381,293
Across 2 rounds since 2019
Latest share price
$2.00
Elevate Equity 1 offering price
Financials
FY2017–FY2018 · from SEC filings · hover any figure for its source$82K
−$19K
2017
$98K
$4K
2018
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
Income statement
Revenue
$81,760
$98,314
Cost of goods sold
$74,349
$72,538
Gross margin
9%
26%
Net income
-$19,460
$4,086
Taxes paid
$0
$0
Balance sheet
Cash
$15,643
$3,701
Accounts receivable
$0
$0
Total assets
$37,334
$55,473
Short-term debt
$6,794
$28,347
Long-term debt
$50,000
$42,500
Total liabilities
$56,794
$70,847
Other
Headcount
—
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$5.2M
post-money
Elevate Equity 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $189.4K / $1.1MInvestors 112Post-money $5.2M
Raised $191.9K / $1.1M
Reg CF annual-report compliance
Delinquent
Filed 0 of 7 annual reports (FY2019–FY2025)
Missing: 2019, 2020, 2021, 2022, 2023, 2024, 2025
112 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001791625Share price $2.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.